In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
|Videos|March 11, 2020
Recent Themes in HIV Science
Author(s)Contagion® Editorial Staff
Colleen Kelley, MD, MPH, associate professor at the Emory University School of Medicine, discusses some of the ongoing themes in developing HIV science.
Advertisement
Segment Description: Colleen Kelley, MD, MPH, associate professor at the Emory University School of Medicine, discusses some of the themes in developing HIV science.
Interview Transcript (modified slightly for readability):
Kelley: Some of the biggest themes continue to be prevention and cure. The new prevention modalities, including preexposure prophylaxis, but also monoclonal antibodies, and hopefully a traditional vaccine, are very exciting. And then the cure agenda.
Every year we continue to learn more about how we might be able to cure people with HIV. We're not there yet. But I think that the science is moving quickly. There have been a lot of advances that are moving us forward and hopefully at some point will give us the key to curing people of HIV.
Advertisement
Related to this article
With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
Here is a review of glucagon-like peptide-1 receptor agonist use in people with HIV.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Advertisement
Advertisement
Trending on Contagion Live
1
CDC Tracking 4 Active Foodborne Outbreaks
2
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
3
VYD2311 Shows Superior Tolerability to mRNA COVID-19 Vaccine in Phase 3 Study
4
On World Rabies Day, When to Seek Treatment, Clinical Considerations for Post Exposure Prophylaxis
5